Skip to content

The Efficacy and Safety of Utilizing EMLA Cream to Improve Double-lumen Tube Tolerance

The Efficacy and Safety of Utilizing EMLA Cream to Improve Double-lumen Tube Tolerance: a Randomized Double-Blind Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011055
Enrollment
Unknown
Registered
2017-04-04
Start date
2015-09-22
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elective video-assisted thoracic surgical lobectomy

Interventions

EMLA group 1:EMLA cream 2g was applied to the cuff of the double-lumen tube
control group:White vaseline was applied to the cuff of the double-lumen tube
EMLA group 2:EMLA cream 3g was applied to the cuff of the double-lumen tube

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients were eligible for enrollment in this randomized double-blind controlled trial if they were 1) undergoing elective video-assisted thoracoscopic lobectomy of 2 hours duration and 2) had ASA physical status I or II

Exclusion criteria

Exclusion criteria: Patients were excluded if 1) difficult tracheal intubation was anticipated; 2) they were cigarette smokers; 3) they had history of respiratory disease or recent respiratory tract infection; 4) they had hypersensitivity to lidocaine or other local anesthetics; or 5) if the trachea was not intubated at the first attempt.

Design outcomes

Primary

MeasureTime frame
hemodynamic responses;coughing;lidocaine and prilocaine blood levels;

Countries

China

Contacts

Public ContactFengyi

Peking University People's Hospital

yifeng65@sina.com+86 13601083503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026